Profil
Dganit Bar worked as an Executive Director-Science & Technology at BioLineRx Ltd. from 2004 to 2012.
Prior to that, she was the Head-Cancer Research at QBI Enterprises Ltd. from 2000 to 2004.
From 2012 to 2017, she served as the Chief Scientific Officer at Rosetta Genomics Ltd. Dr. Bar completed her undergraduate degree at The Hebrew University of Jerusalem and her graduate and doctorate degrees at Ben-Gurion University of the Negev.
Anciens postes connus de Dganit Bar
| Sociétés | Poste | Fin |
|---|---|---|
| ROSETTA GENOMICS LTD. | Directeur Technique/Scientifique/R&D | 14/03/2017 |
| BIOLINERX LTD. | Directeur Technique/Scientifique/R&D | 01/01/2012 |
QBI Enterprises Ltd.
QBI Enterprises Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapeutics | Corporate Officer/Principal | 01/01/2004 |
Formation de Dganit Bar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Rosetta Genomics Ltd.
Rosetta Genomics Ltd. BiotechnologyHealth Technology Provides therapeutic, diagnostic product development and medical research services | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLineRx Ltd.
BioLineRx Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes cell transplantation products | Health Technology |
QBI Enterprises Ltd.
QBI Enterprises Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapeutics | Health Technology |
















